Dr. Paul Petrakos, DO

Dr. Petrakos practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Petrakos' NPI, 1134545171, was assigned on March 14, 2014. Dr. Petrakos graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2013. Dr. Petrakos holds New York license 294458.

Dr. Petrakos' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Petrakos' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Petrakos to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petrakos practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Petrakos' primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Petrakos is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Petrakos is licensed in New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Petrakos treats.

CMS data shows 4,187 Medicare services from Dr. Petrakos across 16 procedure codes in 2024, for 839 Medicare patients. Medicare paid $278,237 for them.

CMS counts 839 Medicare patients who saw Dr. Petrakos in 2024. The largest group is 75 to 84, with 354 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Petrakos' median patient age at 66, with 52% women.

In 2024, Dr. Petrakos wrote 3,146 Medicare Part D claims for 626 patients. 61% of them were for generic drugs. CMS names the drug for 3,040 of them, across 28 drugs with 11 or more claims each, at $465,836 in total drug cost. In 2023, CMS named 3,034 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Petrakos for performance year 2024, reported through an alternative payment model (APM). Dr. Petrakos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 224 procedures of cataract surgery by Dr. Petrakos, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Petrakos, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Glaucoma. Dr. Petrakos has published most often in Orbit. Dr. Petrakos' most frequent co-authors are David Anthony Belyea, MD, Jason Lin Chien, MD and Christiana Loredana Gandy, MD.

CMS Open Payments shows 28 general payments to Dr. Petrakos from 10 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 60% of the total. Bausch & Lomb Americas Inc. paid the most, $1,771.

Dr. Petrakos graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2013. Dr. Petrakos is a member of AOA.

Dr. Petrakos is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.